Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10191402" target="_blank" >RIV/00179906:_____/13:10191402 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/60162694:G44__/13:43874905

Výsledek na webu

<a href="http://dx.doi.org/10.4161/hv.22766" target="_blank" >http://dx.doi.org/10.4161/hv.22766</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4161/hv.22766" target="_blank" >10.4161/hv.22766</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)

Popis výsledku v původním jazyce

Tick-borne encephalitis (TBE) is a viral neurological zoonotic disease transmitted to humans by ticks or by consumption of unpasteurised dairy products from infected cows, goats, or sheep. TBE is highly endemic in areas of Central and Eastern Europe andRussia where it is a major public health concern. However, it is difficult to diagnose TBE as clinical manifestations tend to be relatively nonspecific and a standardised case definition does not exist across the region. TBE is becoming more important inEurope due to the appearance of new endemic areas. Few Central European Vaccination Awareness Group (CEVAG) member countries have implemented universal vaccination programmes against TBE and vaccination coverage is not considered sufficient to control the disease. When implemented, immunization strategies only apply to risk groups under certain conditions, with no harmonised recommendations available to date across the region. Effective vaccination programmes are essential in preventing

Název v anglickém jazyce

Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG)

Popis výsledku anglicky

Tick-borne encephalitis (TBE) is a viral neurological zoonotic disease transmitted to humans by ticks or by consumption of unpasteurised dairy products from infected cows, goats, or sheep. TBE is highly endemic in areas of Central and Eastern Europe andRussia where it is a major public health concern. However, it is difficult to diagnose TBE as clinical manifestations tend to be relatively nonspecific and a standardised case definition does not exist across the region. TBE is becoming more important inEurope due to the appearance of new endemic areas. Few Central European Vaccination Awareness Group (CEVAG) member countries have implemented universal vaccination programmes against TBE and vaccination coverage is not considered sufficient to control the disease. When implemented, immunization strategies only apply to risk groups under certain conditions, with no harmonised recommendations available to date across the region. Effective vaccination programmes are essential in preventing

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FN - Epidemiologie, infekční nemoci a klinická imunologie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Human Vaccines and Immunotherapeutics

ISSN

2164-5515

e-ISSN

—

Svazek periodika

9

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

13

Strana od-do

362-374

Kód UT WoS článku

000315938800029

EID výsledku v databázi Scopus

—